Two lawyers specializing in advising clients from the Life Sciences industry have joined Baker McKenzie’s IP/TMT/Life Sciences group: Paweł Hincz (local partner) and Juliusz Krzyżanowski (senior associate).
Paweł Hincz is a legal advisor with more than 12 years of experience in advising entities operating in the healthcare sector and in the area of mergers and acquisitions. He has advised private equity funds on investments in healthcare entities, drug manufacturers, distributors of medical devices, pharmaceutical wholesalers, pharmaceutical industry associations and medical service providers. Before joining Baker McKenzie he managed the Life Sciences Practice at WKB Wierciński, Kwieciński, Baehr Law Office. He graduated from the Adam Mickiewicz University in Poznań and is a member of the District Chamber of Legal Advisors in Warsaw.
Juliusz Krzyżanowski is an advocate specializing in pharmaceutical, medical and food law. He has over 7 years of experience in advising companies operating in the pharmaceutical industry. In the years 2012-2015 he was an advisor to the Minister of Health, then co-managed with Paweł Hincz the Life Sciences Practice at WKC Wierciński, Kwieciński, Baehr Law Office. He is a graduate of Warsaw University.
Baker McKenzie was one of the first law firms to advise pharmaceutical companies on their global expansion 50 years ago. Our healthcare lawyers understand the challenges industry players face and what it takes to overcome them. As trusted advisors to the world's largest pharmaceutical, biotech, medical device and healthcare services companies, our team of more than 500 lawyers includes molecular biology, biotechnology, pharmacology, nursing and bioethics experts as well as former life sciences professionals who apply their expertise to help clients overcome legal and business challenges.
For the past five years, we have ranked number one for healthcare M&A by deal volume, completing more cross-border transactions than any other law firm. Our global healthcare team not only works across borders, but across practice areas to coordinate the worldwide protection of healthcare patents and brands, develop global transfer pricing and tax planning strategies, and represent clients in product liability cases and complex disputes. We also advise on the legal and regulatory aspects of healthcare advertising and marketing, clinical trials, competition and trade, commercial agreements, data privacy, employment issues and market entry.